Biosante Pharmaceuticals Aktie
51,00
EUR
±0,00
EUR
±0,00
%
55,02
USD
+0,43
USD
+0,79
%
Werbung
Biosante Pharmaceuticals Aktie Analyse
16.10.17 | Biosante Pharmaceuticals Buy | Canaccord Adams | |
31.07.17 | Biosante Pharmaceuticals Buy | Canaccord Adams | |
13.11.15 | Biosante Pharmaceuticals Buy | Standpoint Research | |
28.09.15 | Biosante Pharmaceuticals Buy | ROTH Capital Partners, LLC | |
05.08.15 | Biosante Pharmaceuticals Outperform | Oppenheimer & Co. Inc. | |
31.07.15 | Biosante Pharmaceuticals Outperform | Oppenheimer & Co. Inc. | |
23.06.15 | Biosante Pharmaceuticals Outperform | Oppenheimer & Co. Inc. | |
06.05.15 | Biosante Pharmaceuticals Outperform | Oppenheimer & Co. Inc. | |
Werbung
|
|||
26.02.15 | Biosante Pharmaceuticals Buy | ROTH Capital Partners, LLC | |
18.02.15 | Biosante Pharmaceuticals Outperform | Oppenheimer & Co. Inc. | |
20.11.14 | Biosante Pharmaceuticals Buy | ROTH Capital Partners, LLC |
Werbung
Werbung